The key finding
A 2024 systematic review and meta-analysis examined whether transcranial direct current stimulation (tDCS)—a technique that applies gentle electrical currents to the scalp—might benefit cognition in people experiencing memory decline. Analyzing 22 studies with a combined total of 1,074 participants diagnosed with either mild cognitive impairment (MCI) or Alzheimer’s disease (AD), researchers found that tDCS was linked to significant improvements across multiple cognitive measures. Participants who received tDCS alongside standard treatments showed better scores on widely used tests like the Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA) compared to control groups. The technique was also associated with reduced P300 latency—a brain-wave measurement reflecting the speed of information processing.
What the study looked like
This meta-analysis pooled data from 22 individual studies published through February 2023, spanning research databases in both Chinese and English. The 1,074 participants all had diagnoses of MCI or AD, conditions representing a spectrum from early memory concerns to more advanced dementia. Study designs varied, but typically compared groups receiving tDCS plus standard care (such as medication or cognitive stimulation exercises) against control groups receiving standard care alone or standard care with sham tDCS (a placebo version where no actual current is delivered). Researchers extracted outcomes from validated cognitive assessments including the MMSE, MoCA, and Mattis Dementia Rating Scale (MODA), as well as the P300 event-related potential—a neurophysiological measure captured via EEG that reflects how quickly the brain processes new information. Two independent reviewers screened studies and assessed quality using the Cochrane Collaboration’s risk-of-bias criteria, then performed statistical analysis to combine results.
Why researchers think this happened
tDCS works by delivering low-intensity direct electrical current through electrodes placed on the scalp, typically targeting specific brain regions involved in memory and executive function. The prevailing hypothesis is that this stimulation modulates neuronal excitability: anodal (positive) stimulation is thought to increase cortical excitability and enhance synaptic plasticity, while cathodal (negative) stimulation may decrease excitability. In neurodegenerative conditions like MCI and AD, synaptic connections progressively weaken. Researchers theorize that tDCS may temporarily strengthen these connections or compensate for lost function by activating alternative neural pathways. The improvements in P300 latency suggest the technique may enhance the speed of neural transmission and information processing. This aligns with prior research showing tDCS effects on neuroplasticity—the brain’s ability to reorganize and form new connections—which is often impaired in dementia. The combination of tDCS with cognitive training or pharmacotherapy may create synergistic effects, reinforcing learning and memory consolidation.
How to read this carefully
While the pooled results show statistical significance, several limitations warrant caution. The 22 studies varied in tDCS protocols—including electrode placement, stimulation intensity, session duration, and total number of sessions—making it difficult to determine an optimal approach. Sample sizes in individual studies were often modest, and participant characteristics (age, disease severity, concurrent medications) differed across trials. Crucially, this is a meta-analysis of association studies, not proof of causation; we cannot definitively say tDCS causes cognitive improvement, only that it correlates with better test scores under these conditions. Short follow-up periods in many studies mean we don’t know whether benefits persist long-term. Publication bias—the tendency for positive results to be published more often than negative ones—could also skew the apparent effectiveness. Finally, cognitive test scores improved, but whether these changes translate to meaningful real-world function (like remembering appointments or managing finances) remains less clear.
What this means for everyday life
For individuals navigating MCI or early Alzheimer’s, or those supporting loved ones with these conditions, this research suggests tDCS might be worth discussing with healthcare providers as a complementary approach. It’s a non-invasive technique with relatively few side effects reported in the literature, typically involving mild scalp tingling. However, it’s not yet a standard treatment and isn’t widely available outside research or specialized clinical settings. If considering tDCS, look for programs that combine it with proven interventions like cognitive rehabilitation or structured mental exercises, as the studies showing benefit used this combined approach. This isn’t a standalone cure or reversal of dementia, but rather one potential tool in a broader management strategy. Given the evidence is still evolving, maintaining realistic expectations is important—modest improvements in processing speed or test performance, while meaningful, differ from halting disease progression. As always, any new intervention should be integrated into a comprehensive care plan developed with medical professionals.